Nerve Stimulation for Obstructive Sleep Apnea

Previously, people with moderate to severe OSA “who were intolerant to CPAP machines had no other treatment options,” says Aparajitha Verma, MD, a sleep neurologist at UTHealth Houston. “So this is bridging a valuable gap.”
Next up video playing in 10 seconds
9 Lifestyle Tips to Improve Energy With Sleep Apnea
What Is Nerve Stimulation for OSA?
“That’s very significant,” says Joyce Lee-Iannotti, MD, a neurologist and the director of Barrow Neurological Institute's Sleep Center in Phoenix. “It can take you from having moderate sleep apnea to not having sleep apnea at all.” Patients also reported improvements in daytime sleepiness — a hallmark symptom of OSA.
Are You a Candidate for Nerve Stimulation?
- Have moderate to severe sleep apnea (an AHI score of 15 to 100)
- Have a body mass index of 40 or less
- Haven’t been able to tolerate CPAP therapy after trying for at least three months
- Can safely undergo implantation surgery
- Are age 22 or older (though patients as young as 13 may be eligible in some cases.)
If the doctor determines that you have an anteroposterior collapse and would likely benefit from nerve stimulation, they will submit a request to your insurance company to approve the device.
Devices Currently Available
The Implant Process and Recovery
Neither device is activated immediately after the procedure. For Inspire, you’ll typically wait six weeks to allow the implant site and surrounding nerve to heal, Verma says. For Genio, you’ll wait eight weeks.
The Inspire device is usually activated in the sleep medicine physician’s office. “We slowly introduce a very minimal voltage and see what the patient’s reaction is. Are they sensing it? Then we slowly advance the settings until the patient can feel it,” Verma says. You’ll use that setting as a baseline and gradually increase the voltage by one setting per week.
If the next week’s setting feels too intense — you may feel your tongue is being pulled too hard — Verma advises staying at the lower setting for a couple more days before trying again. "It's like training a muscle in the gym,” she says. “The more you lift a weight, the more you get used to it.”
It takes approximately six to eight weeks from the date of activation for people to reach their final setting, though some people may need three or four months, she adds.
Potential Risks and Complications
“Overall, hypoglossal nerve stimulation is considered safe, but as with any surgical procedure, there are risks,” Lee-Iannotti says, including infection, bleeding, lasting pain, nerve injury, and device displacement, which may require revision surgery.
- Fever higher than 100.5
- Excessive swelling or redness at the incision site
- Bleeding from incisions
- Slurred speech or difficulty breathing or swallowing that doesn’t improve
Long-Term Maintenance and Monitoring
The Takeaway
- Hypoglossal nerve stimulation is an effective treatment for people with obstructive sleep apnea who can’t tolerate continuous positive airway pressure therapy.
- The treatment uses an implanted device to deliver gentle electrical pulses to the nerve that controls the muscles of the tongue, keeping the tongue from blocking airflow during sleep.
- Research shows that nerve stimulation significantly improves the apnea-hypopnea index and daytime sleepiness.
- Nerve stimulation carries some risks, including infection, bleeding, lasting pain, nerve injury, and device displacement. See your doctor if you develop a fever; excessive swelling, redness, or bleeding at the incision site; or breathing, swallowing, or speech problems that don’t improve.
Resources We Trust
- Cleveland Clinic: Sleep Apnea Implant
- Johns Hopkins Medicine: Hypoglossal Nerve Stimulation Implant for Sleep Apnea
- National Heart, Lung, and Blood Institute: Sleep Apnea Treatment
- University of Iowa: Drug-Induced Sleep Endoscopy (DISE)
- American Academy of Sleep Medicine: Sleep Center Directory
- Qiao M et al. Long Term Adherence to Continuous Positive Airway Pressure in Mild Obstructive Sleep Apnea. BMC Pulmonary Medicine. September 1, 2023.
- Hypoglossal Nerve Stimulation Implant for Sleep Apnea. Johns Hopkins Medicine.
- Alrubasy WA. Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea in Adults: An Updated Systematic Review and Meta-Analysis. Respiratory Medicine. November-December 2024.
- Inspire Upper Airway Stimulation - P130008/S090. U.S. Food and Drug Administration. July 13, 2023.
- Sorenson KR et al. Managing Complete Concentric Collapse in Obstructive Sleep Apnea: A Narrative Review. Cureus. September 9, 2025.
- Summary of Safety and Effectiveness Data (SSED). U.S. Food and Drug Administration. June 8, 2023.
- Nyxoah Receives FDA Approval for Genio System. American Academy of Sleep Medicine. August 15, 2025.
- Heiser C et al. Bilateral vs Unilateral Hypoglossal Nerve Stimulation in Patients With Obstructive Sleep Apnea. OTO Open. July 6, 2022.
- Hypoglossal Nerve Stimulation Implant. Barrow Neurological Institute. April 7, 2025.
- Sleep Apnea Implant. Cleveland Clinic. February 19, 2025.
- The Genio System. Genio.
- Postoperative Instructions for Inspire Hypoglossal Nerve Stimulator. UMMC Health Care.
- Han CJ et al. Impact of Postoperative Weight Changes on Hypoglossal Nerve Stimulation Success for Obstructive Sleep Apnea. Otolaryngology — Head and Neck Surgery. May 29, 2025.

Abhinav Singh, MD
Medical Reviewer
Abhinav Singh, MD, is a board-certified sleep medicine specialist and the medical director of the Indiana Sleep Center. He is also an associate clinical professor at Marian Univers...
